Immune Reconstitution Post-αβ T-Cell/CD19 B-Cell Depleted Haploidentical HSCT
Valentina Bertaina, MSc, Bambino Gesù Children’s Hospital, presents on “Long-Term Data on Immune Monitoring of Children Given TCR αβ /CD19 Cell Depleted HLA-Haploidentical Stem Cell Transplantation (Haplo-HSCT),” and Rosa Bacchetta, MD, Stanford University, presents on “Characterization of Immune Reconstitution in Pediatric and Young Adult Patients with Hematologic Malignancies, Treated With T-allo10 Infusion Post αβ Depleted-HSCT” at the 2024 International Symposium on αβ T-Cell/CD19 B-Cell Depleted Haploidentical Stem Cell Transplantation.
